Sanofi (SNY) Asset Utilization Ratio (2018 - 2026)

Sanofi (SNY) posted Asset Utilization Ratio of 0.35 for Q1 2026, up 4.47% sequentially from 0.33 in Q4 2025, and up 18.91% YoY from 0.29 in Q1 2025.

Sanofi (SNY) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Sanofi (SNY) has 3 years of Asset Utilization Ratio data on file, last reported at 0.35 in Q1 2026.

Quarterly Asset Utilization Ratio rose 18.91% year-over-year to 0.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.35 (up 18.91% YoY) and the FY2025 annual result came in at 0.35, up 11.36% from the prior year.
Asset Utilization Ratio improved to 0.35 in Q1 2026 per SNY's latest filing, from 0.33 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.45 in Q3 2025, with the low at 0.29 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	0.63
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	0.48
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	0.46
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	0.50
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	0.50
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	0.41
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	0.52
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	0.12
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Sanofi	-	-	9.49 Bn	0.35

Download Data